D-0921-2017 Class II Terminated

Recalled by Lucid Pharma LLC — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
June 28, 2017
Initiation Date
June 1, 2017
Termination Date
September 25, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 44168 bottles; b) 24960 bottles

Product Description

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

Reason for Recall

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18